Tari Hafner v. HHS - Influenza, idiopathic thrombocytopenic purpura (ITP) (2020)
Case summary [AI summaries can sometimes make mistakes]
On April 14, 2017, petitioner Tari Hafner filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she suffered idiopathic thrombocytopenic purpura (ITP) as a result of receiving an influenza (flu) vaccination on September 21, 2015. Petitioner further alleged that she suffered residual effects from this injury for more than six months.
The respondent denied that the flu vaccine caused petitioner's ITP or any other injury. Despite the respondent's denial, the parties filed a joint stipulation on April 17, 2020, agreeing to an award of compensation.
Special Master Daniel T. Horner reviewed the stipulation and found it reasonable.
The decision adopted the stipulation, awarding Tari Hafner a lump sum of $100,000.00, payable to the petitioner, as compensation for all items of damages. The decision was issued on May 12, 2020.
The public decision does not describe the specific onset of symptoms, medical tests performed, treatments received, or the mechanism by which the vaccine allegedly caused the ITP. Petitioner was represented by Sidney P.
Cominsky, and respondent was represented by Kyle Edward Pozza.
Theory of causation
Petitioner Tari Hafner received an influenza vaccine on September 21, 2015, and subsequently alleged developing idiopathic thrombocytopenic purpura (ITP) with residual effects lasting more than six months. Respondent denied the vaccine caused the ITP. The parties filed a joint stipulation for compensation, which Special Master Daniel T. Horner adopted. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. The outcome was a compensated award of $100,000.00. The decision date was May 12, 2020. Petitioner's counsel was Sidney P. Cominsky, and respondent's counsel was Kyle Edward Pozza.
Source PDFs
USCOURTS-cofc-1_17-vv-00526